Abstract: A method for processing a video according to the present invention may comprise: generating a plurality of Most Probable Mode (MPM) candidates; determining whether there is an MPM candidate identical to an intra-prediction mode of a current block among the plurality of MPM candidates; obtaining the intra-prediction mode of the current block, based on a result of the determining; and performing an intra-prediction for the current block, based on the intra-prediction mode of the current block.

Abstract: A storage device may load, between a first time point at which information on candidate memory regions among a plurality of memory regions is started to be sent to an external device and a second time point at which a command requesting a map segment for a target memory region among the plurality of memory regions is received from the external device, all or a part of map segments corresponding to the candidate memory regions into a buffer.

Abstract: A camera module having a first housing; a lens module disposed in the first housing; a second housing coupled to the first housing; a first printed circuit board disposed in the inner space of the first housing and the second housing; an image sensor disposed on the first printed circuit board; and a shield can disposed under the first printed circuit board in the second housing. The shield can comprises a rib which comes into contact with the lower surface of the first printed circuit board.

Abstract: A storage device may determine write throughput based on a plurality of write commands received from the outside of the storage device, and write target data write-requested from the outside to a first memory area including one or more of a plurality of first type memory blocks or a second memory area including one or more of a second type memory blocks according to whether the write throughput is greater than or equal to a threshold throughput. The first type memory blocks may operate at a higher speed than the second type memory blocks.

Abstract: Provided are L-glufosinate intermediate preparation method or L-glufosinate preparation method, the method, for preparing L-glufosinate intermediate or L-glufosinate from an L-homoserine derivative, comprising a step of preparing a compound of Chemical Formula 2 from a compound of Chemical Formula 1.

Abstract: An anti-chitinase-3-like protein 1 antibody or antigen-binding fragment thereof of the present invention comprises a light chain variable region comprising CDRs of table 1 and a heavy chain variable region comprising CDRs of table 2. The antibody is capable of specifically binding to chitinase-3-like protein 1 (CHI3L1) and thus can be used for the prevention or treatment of a CHI3L1-associated disease, or for the diagnosis of the disease.

Abstract: An electrode assembly, a manufacturing method, an ultrasonic cutting device, a cylindrical battery including the electrode assembly, a battery pack and a vehicle including the same are provided. In the electrode assembly, two electrodes and a separator interposed therebetween are wound about an axis, at least one of the electrodes includes an uncoated portion provided at a long side end, a winding turn region of the uncoated portion is provided at one end of the electrode assembly, the winding turn region includes a cut portion and a bent portion alternately disposed along a circumferential direction of the electrode assembly, an axial height of the cut portion is smaller than an axial height of the bent portion, the bent portion includes a plurality of uncoated portion flags, and the plurality of uncoated portion flags overlap along and axial direction to define a bending surface region.

Abstract: The present disclosure relates to a lithium secondary battery with improved safety during thermal runaway. The lithium secondary battery includes a positive electrode including a positive electrode active material, a negative electrode including a negative electrode active material, and an electrolyte, and has a nominal voltage of 3.68 V or greater, and VP represented by Equation (1) below is 4 mbar·Ah?1·sec?1 or less: Equation (1): VP=?P/(tmax×C).

Abstract: The present disclosure relates to a lithium secondary battery with improved safety during thermal runaway. The lithium secondary battery includes a positive electrode including a positive electrode active material, a negative electrode including a negative electrode active material, and an electrolyte, and has a nominal voltage of 3.68 V or greater, and VP represented by Equation (1) below is 4 mbar·Ah?1·sec?1 or less: Equation (1): VP=?P/(tmax×C).

Abstract: The present disclosure relates to a lithium secondary battery with improved safety during thermal runaway. The lithium secondary battery includes a positive electrode including a positive electrode active material, a negative electrode including a negative electrode active material, and an electrolyte, and has a nominal voltage of 3.68 V or greater, and VT represented by Equation (1) below measured after manufacturing a test module by stacking four of the lithium secondary battery fully charged by being charged to 4.35 V is 4 Ah/sec or less: Equation (1): VT=Ctotal/t.

Abstract: The present disclosure relates to a lithium secondary battery with improved safety during thermal runaway. The lithium secondary battery includes a positive electrode including a positive electrode active material, a negative electrode including a negative electrode active material, and an electrolyte, and has a nominal voltage of 3.68 V or greater, and VT represented by Equation (1) below measured after manufacturing a test module by stacking four of the lithium secondary battery fully charged by being charged to 4.35 V is 4 Ah/sec or less: Equation (1): VT=Ctotal/t.

Abstract: A nicotinamide adenine dinucleotide phosphate-dependent steroid dehydrogenase-like (NSDHL) inhibitor provided according to an aspect of the present invention can be used not only as an anticancer agent capable of overcoming resistance to EGFR-targeting anticancer agents, but also advantageously in the treatment of hyperlipidemia.

Abstract: A method of developing a digital therapy solution through a modular digital therapy framework and an apparatus using the method can include receiving, by a digital therapy solution generator, digital therapy solution data; and generating, by the digital therapy solution generator, a digital therapy solution based on the digital therapy solution data.

Abstract: A method of patient reporting based on a voice using artificial intelligence (AI) and an apparatus for performing the method can include receiving, by a patient analysis device, patient analysis basic information, and generating, by the patient analysis device, report basic information based on the patient analysis basic information. the method and apparatus can also include generating, by a patient report generation device, a patient report based on the report basic information.

Abstract: A method of managing a medication prescription and dosage on the basis of a biomarker and an apparatus for performing the same can include receiving, by a prescription management device, user data and generating, by the prescription management device, prescription data on the basis of the user data.

Abstract: A method of disease management using voice data and an apparatus for performing the method can including receiving, by a voice based disease management device, user's voice data. The method and apparatus can also include generating, by the voice based disease management device, disease management data based on the voice data. Optionally, the step of generating disease management data can include extracting context data and out-of-context data based on the voice data.

Abstract: A method of generating a customized digital therapeutic on the basis of multi-source data analysis and an apparatus for performing the same can include receiving, by a digital therapeutic generation device, user data and generating, by the digital therapeutic generation device, a digital therapeutic personalized for a user on the basis of the user data.

Abstract: An electrode assembly includes electrodes and a first separator sheet in which the electrodes and first separator sheet portions of the first separator sheet are alternately stacked. The electrode comprises a first electrode and a second electrode. The first separator sheet has a zigzag shape formed by being folded at least twice. A length of the second electrode is shorter than a length of the first electrode. the electrode assembly includes a molding member located between a first section of the first separator sheet wrapping the second electrode and a first outer side surface of the electrode assembly and between the second electrode and a second outer side surface of the electrode assembly.

Abstract: A predictive analysis method for disease progression monitoring and management and an apparatus for performing the method can include receiving, by a disease management device, user data and generating, by the disease management device, user disease management data based on the user data. The disease management data can include disease prediction data for a user or disease monitoring data for the user.

Abstract: A light emitting device may include a first semiconductor layer; an active layer disposed on the first semiconductor layer; a second semiconductor layer disposed on the active layer; an electrode layer disposed on the second semiconductor layer; a protective layer disposed on the electrode layer; and an insulating film enclosing outer circumferential surfaces of at least the first semiconductor layer, the active layer, the second semiconductor layer, and the electrode layer, and exposing a surface of the first semiconductor layer and a surface of the protective layer.